Literature DB >> 28398539

Bile Cast Nephropathy in Cirrhotic Patients: Effects of Chronic Hyperbilirubinemia.

Michelle Foshat1, Heather M Ruff1, Wayne G Fischer2, Robert E Beach3, Mark R Fowler1, Hyunsu Ju4, Judith F Aronson1, Marjan Afrouzian1,2.   

Abstract

OBJECTIVES: The aim of this study was to determine the prevalence of bile cast nephropathy (BCN) in autopsied cirrhotic patients and to correlate BCN with clinical and laboratory data to direct attention to this underrecognized renal complication of liver failure.
METHODS: We assessed 114 autopsy cases of cirrhosis for the presence of renal intratubular bile casts using Hall stain for bile. Presence of bile casts was correlated with etiology of cirrhosis, clinical and laboratory data, and histologic findings.
RESULTS: Bile casts were identified in 55% of cases. The most common etiology of cirrhosis was hepatitis C virus (HCV) infection (52%), and serum creatinine ( P  = .02) and serum urea nitrogen ( P  = .01) were significantly higher in the Hall-positive group. Conjugated bilirubin was below 20 mg/dL in 90%, and levels below 10 mg/dL were noted in 80% of cases.
CONCLUSIONS: To our knowledge, this is the largest study of BCN in human subjects and a first report describing the association of BCN with HCV-related cirrhosis. We demonstrated that in the face of protracted chronic hyperbilirubinemia, bile casts are formed at much lower bilirubin levels than previously thought. Furthermore, we proposed an algorithm to assist in better identification of bile casts. © American Society for Clinical Pathology, 2017. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com

Entities:  

Keywords:  Bile cast nephropathy; Cirrhosis; Hyperbilirubinemia

Mesh:

Year:  2017        PMID: 28398539     DOI: 10.1093/ajcp/aqx030

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  6 in total

Review 1.  Reappraising the spectrum of AKI and hepatorenal syndrome in patients with cirrhosis.

Authors:  Juan Carlos Q Velez; George Therapondos; Luis A Juncos
Journal:  Nat Rev Nephrol       Date:  2019-11-13       Impact factor: 28.314

2.  Bile Acids Are Important Contributors to AKI Associated with Liver Disease: PRO.

Authors:  Peter Fickert; Alexander R Rosenkranz
Journal:  Kidney360       Date:  2021-05-03

3.  Renal tubular injury in hyperbilirubinemia: Bile cast nephropathy.

Authors:  Xun Zhao; Ruiyao Huang; Philip Wong; Pierre-Oliver Fiset; Marc Deschênes
Journal:  Can Liver J       Date:  2021-08-09

Review 4.  Bile Cast Nephropathy: A Comprehensive Review.

Authors:  Manoj R Somagutta; Molly S Jain; Maria Kezia Lourdes Pormento; Siva K Pendyala; Narayana Reddy Bathula; Nagendrababu Jarapala; Ashwini Mahadevaiah; Nayana Sasidharan; Mohamed A Gad; Greta Mahmutaj; Namrata Hange
Journal:  Cureus       Date:  2022-03-29

5.  Silymarin mitigates bile duct obstruction-induced cholemic nephropathy.

Authors:  Mohammad Mehdi Ommati; Omid Farshad; Negar Azarpira; Elmira Ghazanfari; Hossein Niknahad; Reza Heidari
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2021-02-04       Impact factor: 3.000

6.  Pentoxifylline mitigates cholestasis-related cholemic nephropathy.

Authors:  Mohammad Mehdi Ommati; Sara Hojatnezhad; Narges Abdoli; Ram Kumar Manthari; Zhipeng Jia; Asma Najibi; Amin Reza Akbarizadeh; Issa Sadeghian; Omid Farshad; Negar Azarpira; Hossein Niknahad; Reza Heidari
Journal:  Clin Exp Hepatol       Date:  2021-11-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.